Alnylam PharmaceuticalsRecent Data Breaches and Security Report

https://alnylam.com  ᛫  Biotech & Pharmaceuticals
Last updated October 26, 2018

Company Details

Company Overview

Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Valuation

Employees

CEO

John M. Maraganore

Location

Recent Data Breaches

Stay informed about the most recent data breaches affecting companies like Alnylam Pharmaceuticals

subscribe to data breach notifications

Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's CSTAR Score ranges from 0 to 950. The higher the score, the more effective a company is in implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Alnylam Pharmaceuticals

Get full security report ›

See UpGuard In Action

Book a call with one of our specialists and we'll arrange a time for a demo.